Completed

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language 
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding under this funding opportunity.

Executive Summary
The U.S. Embassy to the United Kingdom of the U.S. Department of State is pleased to announce that funding is available through its Public Diplomacy Section program. This is an Annual Program Statement, outlining our funding priorities, the strategic themes we focus on, and the procedures for submitting requests for funding.
 

Limit: 1 // Tickets Available: 0 

S. Song (Biomedical Engineering)

Limiting Language
One nominated candidate per eligible institution is accepted per year

Program Overview
The Rita Allen Foundation Scholars program funds basic biomedical research in the fields of cancer, immunology, and neuroscience, as well as pain, through the Rita Allen Foundation Award in Pain. The Rita Allen Foundation Scholars program has supported more than 200 scientists since 1976. The program embraces innovative research with above-average risk and groundbreaking possibilities. Scholars have gone on to win the Nobel Prize in Physiology or Medicine, the National Medal of Science, the Wolf Prize in Medicine and the Breakthrough Prize in Life Sciences.

Full sponsor guidelines are linked here. 

Award Amount
Scholars can receive up to $110,000 per year for a maximum of five years. Recipients of the Award in Pain can be granted $50,000 per year for up to three years.

Eligibility
To be eligible for a Rita Allen Foundation Scholars Award, candidates must either apply through the Scholars Award in Pain or be nominated by an eligible institution and have completed their training and provided persuasive evidence of distinguished achievement or extraordinary promise in research in one of the relevant fields (cancer, immunology, neuroscience. or pain). United States citizenship is not a requirement; however, awardees must be legally employed at the time of application at a U.S. degree-granting or research institution that is an invited participant in the Rita Allen Foundation Scholars Program. Awards are made to the 501(c)(3) organization; awards are not made to an individual. Scholars must perform research at a non-profit institution in the U.S. during the entire period of Rita Allen Foundation support.

Institutions should consider the following when considering whom to nominate for the Rita Allen Foundation Scholars program: 

• Candidates should be independent investigators in the early stages of their careers and research. 
• The caliber of early-stage investigators suggests nominees would be appointed to tenure-track positions at their respective institutions. 
• It is preferable that candidates be in the first three years of their tenure track. (This is taken into consideration in the rating of applications by the Scientific Advisory Committee.) 
• A senior postdoc should not be a candidate; wait until s/he is in a tenure-track position, as described. 
• Associate professors should not be candidates. 
• Candidates must have received committed startup funds from their respective institutions. 
• Candidates must have lab space from their institutions. 

Rita Allen Foundation Scholars may not accept an award from the Beckman Young Investigator Program, Pew Scholars Program in the Biomedical Sciences, Searle Scholars Program, or Vallee Scholars Program that would take effect beginning in year one of the RAF award. Rita Allen Scholars may apply for awards from these organizations that would take effect beginning in year two of the RAF award. Other sources of funding also may influence selection. 

No Applicants // Limit: 1 (COM-T) // Tickets Available: 1 

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Purpose
The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in states ranked in the top quartile for projected primary care provider shortages. to expand or enhance education for medical students preparing to become physicians. This expansion can include funding for direct student supports which help students be successful in medical school, as well as for infrastructure development, maintenance, equipment, and minor renovations or alterations. The program is designed to prepare and encourage medical students to choose residencies and careers in primary care and serve Tribal, rural and other areas with primary care provider shortages in those states after they complete their residency.

• Increase the number of primary care physicians practicing in states with a projected primary care physician shortage, particularly in rural Tribal and other areas with primary care provider shortages.

Full sponsor guidelines are linked here. 
 

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs.  Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. 

Full sponsor guidelines are linked here. 

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language 
An eligible institution may not submit more than one application to this program as a lead institution. This includes applications from subordinate units under a parent institution. Additionally, eligible recipients may only receive funds for one award at a time. Prospective applicants are advised to contact their institutional sponsored projects office regarding processes used to select proposals for submission. For RFAP purposes, ‘parent institution’ refers to the single, legally distinct institution of higher education that oversees its colleges, schools, and departments. A separate UEI by itself does not automatically make a campus or unit a different institution. Some campuses, divisions, or administrative units within a university system may maintain their own UEIs for grants management purposes while still operating under the governance, accreditation, and legal identity of a single parent institution. In such cases, the parent institution, not the UEI, is the controlling factor in determining the one application limit. The one application limit applies to all subordinate units under the same institution. However, university systems with multiple independently accredited and governed institutions may submit one application per institution within the system. A multi campus university system may submit more than one application only if each campus is recognized as a distinct institution based on its own independent accreditation, governance structure, and institutional identity. Institutions that have received congressionally directed funding for research facility projects are not excluded from participation in this program. Such institutions may submit applications and compete for additional projects under this competitive funding opportunity. 

Cost Sharing Requirements
Applicants MUST provide at minimum a 1:1 matching contribution on a dollar-for-dollar basis for all Federal funds awarded under the RFAP. The non-Federal share must be paid in cash and may include funding from private sources or from units of State or local government. In-kind matching will not be considered. See 7 U.S.C. 390a(c)(2)(A). The full match amount must be budgeted in the application, with sources of funding clearly disclosed. Recipients may phase matching contributions, potentially synchronized with project construction milestones, or raise additional funds during the project period, provided that the Authorized Representative signs the award, thereby attesting to fulfill all match commitments. Matching costs must be incurred during the federal award period, align with 2 CFR 200.306 requirements (verifiable, allowable, not double counted, and included in the approved budget), and be properly documented and reported cumulatively via the SF425 Federal Financial Reports throughout and at the conclusion of the project Consistent with 48 U.S.C. 1469a, notwithstanding any other provision of law, in the case of American Samoa, Guam, the Virgin Islands, the Federated States of Micronesia, and the Northern Mariana Islands, NIFA will waive any requirement for local matching funds under $200,000 (including in-kind contributions). 

Executive Summary
This notice identifies the objectives for RCDG program projects, deadlines, funding information, eligibility criteria for projects and applicants, and application forms and associated instructions. NIFA requests applications for grants under the RCDG program for FY 2026 to improve the economic condition of rural areas by helping nonprofit organizations who in turn provide technical assistance to start, expand, or improve cooperatives and mutually owned businesses in rural areas. This notice is being issued to allow applicants sufficient time to leverage financing and prepare and submit their applications.  

Estimated funding amounts are not guaranteed and are subject to the availability of appropriated funds.

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
If an organization submits multiple applications for this or other Harwood funding opportunities, OSHA will review the last viable application package submitted.

Grant Types

• Targeted Topic Training 
  Supports educational programs that identify and prevent workplace hazards and requires applicants to conduct training on OSHA-designated workplace safety and health hazards
• Training and Educational Materials Development
  Supports the.development of quality, classroom-ready training and educational materials that identify and prevent workplace hazards.
  
   

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

Purpose
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.

Full sponsor guidelines are linked here. 

Institutionally Coordinated, please contact limited submissions if you are intersted in applying for the September 2026 deadline. 

Upcoming Webinar
July 8, 2026, at 1:00 pm (EST).

Please register using the link below to secure your spot.
https://scgcorp.zoom.us/webinar/register/WN_yoQC9j2mSAWyu7HcCxD8Dw#/registration 

Limiting Language
Applicant organizations may submit only one application, provided that the type of instrument does not currently exist in the applicant organization (identified by UEI).

Purpose
This Notice of Funding Opportunity (NOFO) aims to build new research capacity and develop a sustainable research program by supporting the purchase of a single commercially available biomedical research instrument currently unavailable in the institution. Instruments funded through this program must be shared among the users to create new research opportunities, enable reproducible data generation, encourage collaborative research and training, and strengthen long-term research capabilities. The minimum award is $50,000. While there is no limit on the total cost of the instrument, the maximum award is $400,000.